The life sciences sector is set for a boost following the launch of NICE Advice, the National Institute for Health and Care Excellence’s support service for pharmaceutical and health technology companies.
The new service combines the offerings of NICE’s previous support services – NICE Scientific Advice and the Officer for Market Access – in one place with more flexibility.
By providing expert insight, the service will help companies get their evidence strategy right first time and gain nationwide market entry as quickly as possible.
Support will span from determining a product’s value, all the way to gathering evidence and gaining market access.
“By engaging with NICE Advice, organisations can benefit from our unrivalled expertise in health technology assessment, depth of knowledge, honest feedback and broad NHS connections.”
Three types of support will be delivered via the service, characterised as advice, insight and education.
- Advice – finding gaps in evidence, providing technical guidance on clinical and economic evidence plans, and quality-checking economic models
- Insight – one hour sessions with a NICE expert or a three-hour engagement with several experts to discuss paths to market and the associated challenges
- Education – free webinars and paid seminars covering evidence generation, economic modelling, NICE evaluations and more
NICE’s interim director of medical technology and digital evaluation, Mark Chapman, said: “NICE Advice provides a single point of contact for individuals and organisations across the life sciences sector.”
He continued: “By coming to us, they’ll gain access to accurate, reliable and actionable advice, NHS insights and education they can trust.”
NICE Advice’s director, Jeanette Kusel, added: “Engaging with us can help save time and money and get innovations into the hands of health and care professionals faster. If you’re unsure about working with NICE, I’d encourage you to come and talk to us.”
To access NICE Advice, click here.
Image credit: iStock
